Navigation Links
InterMune Reports Third Quarter 2012 Financial Results And Business Highlights
Date:11/7/2012

ed to be in a range of $20 to $25 million.  The company anticipates that full-year revenue will be at or slightly above the high end of the range.
  • R&D expense: currently anticipated to be in a range of $90 to $105 million.  The company anticipates that full-year R&D expenses will be at the high end of the range.
  • SG&A expense: currently anticipated to be in a range of $110 to $130 million.  The company anticipates that full-year SG&A expenses will be at the low end of the range.
  • Total Operating Expenses (R&D and SG&A): currently anticipated to be in a range of $200 to $235 million. 
  • Conference Call and Webcast Details
    InterMune will host a live webcast of a conference call today at 4:30 p.m. EST to discuss business highlights and financial results for the third quarter and first nine months of 2012.  Interested investors and others may participate in the conference call by dialing 800-891-8257 (U.S.) or +1-212-271-4651 (international), conference ID# 21610043.  A replay of the webcast and teleconference will be available approximately three hours after the call.

    To access the webcast, please log on to the company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

    A telephonic replay will be available for 10 business days following the call and can be accessed by dialing 800-633-8284 (U.S.) or +1 402-977-9140 (international), and entering conference ID# 21610043.  The webcast will remain available on the company's website until the next earnings call.

    About InterMune
    InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.  In pulmonology, the company is focused on therapies for the tr
    '/>"/>

    SOURCE InterMune, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. InterMune To Release Third Quarter Financial Results On November 7
    2. InterMune To Present At JMP Securities Healthcare Conference
    3. InterMune to Release Fourth Quarter and Full Year Financial Results on February 9
    4. InterMune to Present at J. P. Morgan Healthcare Conference
    5. InterMune to Report Unaudited Fourth Quarter EsbrietĀ® Revenue and Business Update on January 5
    6. PharmAthene Reports Third Quarter 2012 Financial Results
    7. VisionGate Reports Advances In Its Cell-CT(TM) Automated 3D Cell Analysis Platform At ASC 2012 Scientific Meeting
    8. Patient Safety Technologies Reports Third Quarter 2012 Results
    9. PDI Reports 2012 Third Quarter Financial Results
    10. Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
    11. Neurocrine Biosciences Reports Third Quarter 2012 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/26/2015)... June 23, 2015 ... addition of the "Global Cancer Biosimilars Market ... Market introduction of cancer biosimilar is required ... potential. Chemotherapeutic drugs have dominated the cancer segment ... been introduced in past few years. They are ...
    (Date:6/26/2015)... ... , ... ReliantHeart, Inc. , an innovative supplier of advanced mechanical circulatory ... HeartAssist5® LVAD (HA5) to the 68th consecutive implant, there has been no evidence of ... LVAD is referred to as de novo thrombus. De novo thrombus can hide under ...
    (Date:6/25/2015)... 2015 Current asthma medications, which work ... by dilating the airways, can stop working over ... and Women,s Hospital and Harvard Medical School supports ... certain sensory nerve endings in the lungs that ... in the journal Neuron on June ...
    (Date:6/25/2015)... , June 25, 2015  BioMed Realty Trust, ... Inc. (NASDAQ: ILMN ), a world leader in ... power of the genome, has signed a 20-year lease ... research building in Cambridge, England . ... access to the highly skilled workforce in the dynamic ...
    Breaking Biology Technology:Global Cancer Biosimilars Market Opportunity Outlook 2Global Cancer Biosimilars Market Opportunity Outlook 3HeartAssist5® Remote Monitoring has alerted no patterns of de novo thrombus in 68 consecutive implants 2HeartAssist5® Remote Monitoring has alerted no patterns of de novo thrombus in 68 consecutive implants 3Targeting Nerve Endings To Curb Allergic Asthma 2Targeting Nerve Endings To Curb Allergic Asthma 3Targeting Nerve Endings To Curb Allergic Asthma 4Targeting Nerve Endings To Curb Allergic Asthma 5BioMed Realty And Illumina Announce New Build-To-Suit Laboratory Building In Cambridge's Growing Life Science Cluster 2BioMed Realty And Illumina Announce New Build-To-Suit Laboratory Building In Cambridge's Growing Life Science Cluster 3
    ... engineers across Wisconsin are learning new ways to ... sugars, soybeans, solar collectors, corn stover, wind farms, ... , ,State businesses, architects, and builders are national ... save energy and money. , ,Wisconsin policymakers and ...
    ... after the launch of wireless Internet service in downtown Madison, ... service offered by area coffee shops. , ,Now, Mad ... 10-block radius of Madison's Capitol Square and at Dane ... of them. The broadband service will add indoor wireless access ...
    Whitewater, Wis . - Sharon Ethanol , a subsidiary of <a...
    Cached Biology Technology:Wisconsin can offer what a federal energy research lab needs 2Wisconsin can offer what a federal energy research lab needs 3Wisconsin can offer what a federal energy research lab needs 4
    (Date:6/8/2015)... June 8, 2015  The Secure Identity ... selection of Troy Potter of L-3 ... SIBA is a non-profit association that was established ... education and implementation of solutions that protect and ... ...
    (Date:6/4/2015)... 2015  Today, the co-chairs of the Blue Ribbon Study ... biocontainment labs and USA Today,s ... concerns over the findings of lax safety standards and called ... "The state ... said Joe Lieberman , former senator and co-chair of ...
    (Date:6/1/2015)... 1, 2015 According to ... Market by Application (Government, Military & Defense, Healthcare, ... and Security), Technology (Face Recognition, Fingerprint Recognition, Iris ... Recognition, and Others), Function (Contact and Non-Contact) & ... Europe , APAC, Row) - Global ...
    Breaking Biology News(10 mins):Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 2Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 3Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 4Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 5Biodefense Panel Expresses Grave Concerns over Findings at Nation's Research Labs 2Biodefense Panel Expresses Grave Concerns over Findings at Nation's Research Labs 3Next Generation Biometrics Market Worth $24,448.84 Million by 2020 2Next Generation Biometrics Market Worth $24,448.84 Million by 2020 3Next Generation Biometrics Market Worth $24,448.84 Million by 2020 4
    ... In the largest clinical trial to date to examine ... carriers with diseases other than breast and ovarian cancer, ... against advanced pancreatic and prostate cancers. Results of the ... Medicine at the University of Pennsylvania and Sheba Medical ...
    ... Ocean frontier explorer and world-renowned filmmaker James Cameron has ... San Diego as the recipient of the 2013 Nierenberg ... deliver a presentation on his record-setting DEEPSEA CHALLENGE expedition ... on Friday, May 31, on the UC San Diego ...
    ... have developed guidelines being used by foresters and the ... when planting trees., Maps developed by Laura Gray, a ... projections of climatically suitable habitat for tree species based ... , The work, published recently in the journal ...
    Cached Biology News:PARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations 2James Cameron to be publicly honored with Scripps Nierenberg Prize 2James Cameron to be publicly honored with Scripps Nierenberg Prize 3James Cameron to be publicly honored with Scripps Nierenberg Prize 4